Cambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect mutations quicker than current approaches
Some of the key players operating in the in-vitro diagnostics market are Becton Dickinson, Abbott, Johnson & Johnson, BioRad, Luminex, Thermo Fisher Scientific, LivaNova, BioMerieux, Cephied, D
While immunotherapy has transformed the treatment of many cancers, it has failed to make much of an impact in advanced ovarian cancer, and AstraZeneca is hoping to change